{
    "organizations": [],
    "uuid": "60f40f0dabeb0553e7abf5b8fd717b9698dd31f7",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/02/27/the-associated-press-veracyte-reports-4q-loss.html",
    "ord_in_thread": 0,
    "title": "Veracyte reports 4Q loss",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "SOUTH SAN FRANCISCO, Calif. (AP) _ Veracyte Inc. (VCYT) on Tuesday reported a loss of $8.4 million in its fourth quarter.\nOn a per-share basis, the South San Francisco, California-based company said it had a loss of 24 cents.\nThe results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 21 cents per share.\nThe molecular diagnostic company posted revenue of $19.6 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $18.8 million.\nFor the year, the company reported that its loss narrowed to $31 million, or 91 cents per share. Revenue was reported as $72 million.\nVeracyte expects full-year revenue in the range of $81 million to $83 million.\nVeracyte shares have fallen 8 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $6, a decrease of 25 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on VCYT at https://www.zacks.com/ap/VCYT",
    "published": "2018-02-28T02:41:00.000+02:00",
    "crawled": "2018-02-28T02:59:59.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "south",
        "san",
        "francisco",
        "ap",
        "veracyte",
        "vcyt",
        "tuesday",
        "reported",
        "loss",
        "million",
        "fourth",
        "quarter",
        "basis",
        "south",
        "san",
        "francisco",
        "company",
        "said",
        "loss",
        "cent",
        "result",
        "missed",
        "wall",
        "street",
        "expectation",
        "average",
        "estimate",
        "three",
        "analyst",
        "surveyed",
        "zacks",
        "investment",
        "research",
        "loss",
        "cent",
        "per",
        "share",
        "molecular",
        "diagnostic",
        "company",
        "posted",
        "revenue",
        "million",
        "period",
        "surpassing",
        "street",
        "forecast",
        "three",
        "analyst",
        "surveyed",
        "zacks",
        "expected",
        "million",
        "year",
        "company",
        "reported",
        "loss",
        "narrowed",
        "million",
        "cent",
        "per",
        "share",
        "revenue",
        "reported",
        "million",
        "veracyte",
        "expects",
        "revenue",
        "range",
        "million",
        "million",
        "veracyte",
        "share",
        "fallen",
        "percent",
        "since",
        "beginning",
        "year",
        "final",
        "minute",
        "trading",
        "tuesday",
        "share",
        "hit",
        "decrease",
        "percent",
        "last",
        "month",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "vcyt",
        "http"
    ]
}